Evan Loh, President, COO and CMO at Paratek Pharmaceuticals, Inc. (PRTK), sold 3,106 shares at $15.20 ($47K) on 2017-02-06, disclosed to the SEC on 2017-02-08.
Scheduled sale ($47k) by President, COO and CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.05 | 1,082 | $16K | 34.7% |
| 2 | $15.08 | 16 | $241 | 0.5% |
| 3 | $15.09 | 22 | $332 | 0.7% |
| 4 | $15.10 | 1,302 | $20K | 41.9% |
| 5 | $15.15 | 668 | $10K | 21.6% |
| 6 | $15.20 | 16 |
| $243 |
| 0.5% |
| Total | $15.09 avg | 3,106 | $47K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |